John T Cavan Hepion Pharmaceuticals, Inc. (HEPA) insider trading activity
John T Cavan is Chief Financial Officer of Hepion Pharmaceuticals, Inc.. Currently has a direct ownership of 14,800 shares of HEPA, which is worth approximately $9,768. The most recent transaction as insider was on Feb 18, 2021, when has been sold 10,000 shares (Common Stock) at a price of $2.0 per share, resulting in proceeds of $20,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
14.8K
0%
3M change
0%
12M change
Total Value Held
$9,768
John T Cavan Transaction History
JTC
John T Cavan
Chief Financial Officer
Edison, NJ